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Abstract
Background: Appropriate diagnostics to monitor disease trends and assess the effectiveness and impact of interventions
are essential for guiding treatment strategies at different thresholds of schistosomiasis transmission and for certifying
elimination. Field validation of these assays is urgently needed before they can be adopted to support policy decisions of
the national programme for control and elimination of schistosomiasis in P.R. China. We compared the efficacy and utility of
different immunoassays in guiding control strategies and monitoring the endemic status of S. japonicum infections towards
elimination.
Methodology/Principal Findings: A cross-sectional survey was conducted in seven villages with different transmission
intensities settings to assess the performance and utility of three immunoassays, e.g., an indirect hemagglutination assay
(IHA_JX), an enzyme linked immunosorbent assay (ELISA_SZ), and a dot immunogold filtration assay (DIGFA_SH). 6,248
individuals aged 6–65 years old who gave consent and supplied their stool and blood samples were included for data
analysis. Results showed that ELISA_SZ performed significantly higher sensitivity (95.45%, 95%CI: 92.94–97.97%) than
IHA_JX (87.59%, 95%CI: 83.51–91.49%) and DIGFA_SH (79.55%, 95%CI: 74.68–84.41%), especially in subgroups with very low
infection intensity. The specificity of ELISA_SZ, IHA_JX, DIGFA_SH in 6–9 year olds with occasional exposure was nearly 90%.
DIGFA_SH performed the highest screening efficacy for patients among three assays with overall positive predicative value
of 13.07% (95%CI: 11.42–14.72%). We found a positive correlation of antibody positive rate of IHA_JX with results of stool
examination in age strata (r = 0.70, P,0.001). Seropositivity of IHA_JX in children aged 6–9 years old showed an excellent
correlation with prevalence of schistosome infection in the seven communities (r = 0.77, P,0.05).
Conclusions/Significance: Studies suggest that ELISA_SZ could be used to guide selective chemotherapy in moderate or
low endemic regions. IHA_JX could be used to as a surveillance tool and for certifying elimination of schistosomiasis
through monitoring children as a sentinel population.
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Introduction
Following great efforts by the Chinese government and
professionals in public health, the People’s Republic of China
(P.R. China) has became one of the most successful countries in
the world for schistosomiasis control [1–3]. Transmission had been
interrupted in five provinces, Guangdong, Guangxi, Fujian,
Shanghai, and Zhejiang by 1995 [1,4]. The total number of
infected individuals decreased by 90% through 50 years
endeavour [3,5,6]. Due to changes in social and environmental
factors including more migration people with changes in economic
system, serious flood occurred in 1998 along the Yangtze River,
resurgence of schistosomiasis became a public health problem in
P.R.China in the beginning of the new century [3,6,7]. Since
2004, the central government reinforced the national control
programme, and made schistosomiasis one of four priorities for
infectious disease control in P.R.China. The new national goals
aim to transition of the control strategy from morbidity reduction
to transmission control: reduce prevalence of S. japonicum infection
below 5% by 2008 (threshold of infection control) and below 1%
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by 2015 (threshold of transmission control) [6,7]. To reach these
goals, a novel control strategy was initiated in 2004 that aimed at
implementation of integrated human and vector control measures
to reduce the transmission of S. japonicum by blocking egg
contamination of cattle and humans to infect snails [7,8].
Under policy of the national control programme, stages for
schistosomiasis control are classified as morbidity control (preva-
lence over than 5% as defined by stool examination), infection
control (prevalence of 1–5%), transmission control (prevalence
lower than 1%), transmission interruption (no case detected in five
years successively) and elimination (no case detected in another
five years continuously after transmission was interrupted) in P.R.
China [6]. Figure 1 shows current diagnostic approaches in
relation to prevalence, treatment strategies and different control
threshold towards schistosomiasis elimination in P.R. China. As
transmission decreases, simple, affordable and accurate diagnostic
tests are urgently needed for case detection, surveillance and
assessment of the effectiveness of schistosomiasis control interven-
tions. S. japonicum infection is usually determined by the Kato-Katz
thick smear method and the miracidium hatching technique in
P.R.China [9,10]. However, stool examination is laborious and
insensitive for monitoring in endemic areas characterized by very
low prevalence and intensity of the disease, resulting in
underestimation of the prevalence of infection in these regions
[11–14]. Although they cannot be used to distinguish between
current and past infection, immunodiagnostic assays based on
antibody detection have been extensively applied in schistosomi-
asis control programme in P.R. China for years because of their
advantages over parasitological tests including high sensitivity,
rapid time to result, ease of use and ease of batching for population
studies [15–17].
Three types of immunodiagnostic assays have been developed in
P.R. China. Indirect hemagglutination assay (IHA) is currently the
most widely used immunodiagnostic assay as a screening tool
during World Bank Loan Project (WBLP) period and in national
surveillance system on schistosomiasis in P.R. China [4,18,19].
Second, antibody-based enzyme linked immunosorbent assay
(ELISA) was used to estimate the endemic status in the third
nationwide sampling survey of schistosomiasis in P.R. China
followed by Kato-Katz examination of seropositive individuals [6].
Third, rapid diagnostic assays such as dipstick dye immunoassay
(DDIA) and dot immunogold filtration assay (DIGFA), were
developed by Chinese laboratories for detecting cases infected with
S. japonicum [20–22]. Although laboratory-based or epidemiolog-
ical studies have been conducted to investigate the characteristics
of immunoassays mentioned above for diagnosis of schistosomiasis
[23–25], field validation of these assays have not been performed.
These evaluations are urgently needed before they can be adopted
to support policy decisions of the national programme for the
control and elimination of schistosomiasis in P.R. China [26]. In
this study, we sought to demonstrate that parasite density is low in
settings with low prevalence of infection, making it necessary to
switch from microscopy directly to serodiagnostic methods for
surveillance. We will also explore, in low transmission intensity
settings, the relationship between seropositivity and the prevalence
of schistosome infection, as defined by stool examination, and with
the intensity of transmission, as defined by egg count per gram of
stool. As communities approach elimination, schistosome exposure
in children as defined by antibody positivity can be used as
surrogate of continued transmission. In this study, we explore the
relationship between the rates of seropositivity in children and the
prevalence of infection in the village.
Our study aims to validate immunodiagnostic tools that can be
used to guide selective chemotherapy in moderate or low endemic
regions to reduce the number of stool examinations required, to
Figure 1. Chemotherapy strategies and tools for guiding treatment for schistosomiasis control in P.R.China. * Prevalence is calculated
as the percentage of participants who were stool examination positive among the total number of people in the community.
doi:10.1371/journal.pntd.0001408.g001
Author Summary
Immunodiagnostic assays are widely applied in the field to
control schistosomiasis in P.R. China as the prevalence and
infection intensity of schistosome infections decrease.
Field evaluations are urgently needed before they can be
adopted to support policy decisions of the national
programme for the control and elimination of schistoso-
miasis in P.R. China. We carried out a large scale cross-
sectional survey in field settings with different transmis-
sion situations to validate immunodiagnostic tools that
can be used to formulate new schistosomiasis elimination
strategy in P.R. China. Regarding stool examination as gold
reference, the validity and screening efficacy of each
immunodiagnostic kit were calculated and compared with
each other. The association of the prevalence of schisto-
somiasis and antibody positive rates determined by
immunoassays were analyzed using Pearson’s correlation
coefficient values. The study indicates that which test to
use with the elimination strategy is dependent on the
purpose of testing, the endemic status of community and
the resources available. And more sensitive methods need
to be explored and used to target infected individuals for
treatment or to eliminate schistosomiasis.
Elimination Strategies of Schistosomiasis
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identify individuals for treatment in areas with very low
endemicity, and to monitor the high risk population and certify
the elimination of schistosomiasis.
Materials and Methods
Study design
A two-phase approach was used to assess utility of immunoas-
says to monitor S. japonicum infection. First the performance
characteristics of existing and wild-spread used immunodiagnostic
assays were assessed in the laboratory using a well-characterized
serum panel of positive and negative samples. Second, tests with
acceptable performance in phase one and easy to use, were
selected for this study at field locations with different transmission
intensity levels of S. japonicum infections. The results of the
laboratory based evaluation of nine immunoassays have been
reported elsewhere [27]. Three tests, an IHA assay (coded as
IHA_JX), one DIGFA test (coded as DIGFA_SH) and an ELISA
kit (coded as ELISA_SZ), were selected for the field trial based on
their high sensitivity and specificity compared to the enzyme-
linked immunoelectrotransfer blot assay (EITB) as a reference
standard. All three kits detect serum antibodies against schisto-
some soluble egg antigen (SEA). The field studies were carried out
between October to December, 2008. Before the field work and
laboratory examination, experienced staff were selected and then
trained through a training course by National Institute of Parasitic
Diseases. A manual with standard operation procedure for each
reagent was prepared and used for performing the test. 5% serum
specimens and Kato-Katz slides were rechecked by national
institute for quality assurance.
Ethical statement
Written informed consents were obtained from all adult
participants and the parents or legal guardians of children.
Field-based researches were approved by ethics committees of
National Institute of Parasitic Diseases, Chinese Center for Disease
Control and Prevention. And individuals with positive stool
examination results were treated with a single oral dose of
praziquantel (40 mg/kg).
Study areas and population
Field studies were conducted in seven villages, distributed in
three provinces in the middle and lower reaches of Yangtz River in
P.R. China with different estimated prevalence of schistosome
infection based on stool examination. Villages included Caohui,
Jingtou and Xinhua located in Jiangxi Province, Longshang,
Tieguai and Yuye villages in Anhui province, and Hebei village
was administrated by Hubei province. We invited all individuals
aged from 6–65 years old to participate in our surveys. Over 50
grams of stool sample and 5 ml blood sample were collected from
each participant who gave consent. Specimens were taken to local
schistosomiasis stations for testing.
Stool examination
Identification and quantification of S. japonicum eggs were
carried out by the Kato-Katz thick smear method and the
miracidium hatching technique in parallel [10]. Briefly, three
slides (41.7 mg per smear) prepared from a single stool specimen
were read 12–48 h after the initial preparation by two qualified
technicians in a blinded manner. The number of eggs per slide was
counted and recorded. The infection intensity of each individual
was recorded as the number of egg per gram faces (EPG),
calculated by adding up the number of eggs from all three slides
and multiplying by eight to give EPG of stool. The left stool
specimens were tested by miracidium hatching technique [10].
Observation was made at 4, 8, 12 hours after hatching. The result
can be defined as negative if no miracidium was observed.
A patient is defined as positive if positive results were obtained
with any parasitological technique. The infection intensity of
individuals who were tested negative by Kato-Katz method but
positive by miracidium hatching technique were regarded as one
EPG. And participants were regarded as negative if negative
results were obtained with both parasitological methods.
Immunological tests
Blood samples were maintained in a vertical position for several
hours to allow the spontaneous separation of the sera and red
blood cells. The sera were removed into clear tubes and sealed.
Serum specimens were tested by well trained technicians as
following described according to the instructions supplied by the
manufactures. Technicians performing the immunoassays were
unaware of the results of stool examination and any other
immunological test.
For ELISA_SZ, all serum specimens were diluted 1:100 using
the dilution liquid and transferred into the kit supplied microtiter
wells. The incubation procedure, washing steps and detection steps
were carried out according to the manufacturer’s instructions.
Absorbance was read at 450 nm zeroed by the reagent blank wells.
For each run, positive and negative control sera were measured
simultaneously. A positive result was defined as an optical density
(OD) value greater than 2.1 times the OD value of the negative
control serum provided by the kit [24].
For IHA_JX, 100 ml of normal saline was placed into the first
well of the transverse line, whereas 25 ml was added into wells 2
and 3. Then, 25 ml of serum was added to the first well and
thoroughly mixed. 25 ml of mixture was transferred to the second
well and mixed as before while 75 ml of mixture in the first well
was discarded. 25 ml of mixture in the second well was moved into
the third well and mixed followed by discarding 25 ml of them.
Thus, the concentrations of serum in the first, second and third
wells were 1:5, 1:10 and 1:20, respectively. Positive and negative
control sera samples provided by the company were tested
simultaneously on each plate. 25 ml sensitized red blood cell was
placed into each well, shaken, kept at 37uC for 30 min.
Observations were made by the naked eye. The titer in the test
sera was recorded as one dilution before that which yielded a clear,
sharp dark spot similar to that in the negative control wells. Titers
were expressed as reciprocal values. Titers of $10 indicated a
positive result [25].
DIGFA_SH was operated as following four steps: (1) Two drops
of washing buffer from the buffer bottle was added to the well on
the test box and penetrated the membrane completely; (2) 25 ml of
serum was added to the same well and allow it to be absorbed
completely; (3) The membrane was washed as step one followed by
adding four drops of colloidal gold-labeled soluble egg antigen
conjugate from the detecting bottle; (4) After the conjugate
solution was absorbed completely, two drops of washing buffer
were added to well to remove the unbound conjugate and then the
result was read with naked eye immediately. The appearance of
two red dots in the well indicated a positive reaction, and the
appearance of a single red dot indicates a negative reaction [28].
Statistical analysis
Only data from subject who gave consent and from whom both
stool and blood samples were collected were used for analyses.
Using stool examination as a gold reference standard, the
prevalence of infection in each community was calculated as the
percentage of participants who were stool examination positive
Elimination Strategies of Schistosomiasis
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among the total number of participants tested in that village. The
consistency of results determined by stool examination and any
immunoassay was measured by Kappa value.
Using stool examination as a reference standard, the sensitivity
of each test was calculated as the percentage of participants who
were seropositive among those who were positive by stool
examination. Seropositivity represents exposure to schistosomes
and is an aggregate of current and past infection. School aged
children are sentinel population for new infection. The specificity
of immunological testing in a subgroup population of 6–9 years old
was calculated. Specificity of each immunoassay was expressed as
the percentage of individuals who were seronegative among those
who were stool examination negative. Furthermore, in low
transmission intensity settings, it is useful to calculate the ‘‘positive
predicative value’’ (PPV) of screening test by determining the
percentage of those who were stool examination positive among
those who were seropositive. This index gives a measure to
evaluate the screening efficacy of immunoassays of what
percentage of the schistosome exposed population is still shedding
parasite. Comparisons of index between groups were analyzed by
Chi-squared analyses.
The relationships between the prevalence and intensity of
infection in each village, the antibody positive rate determined by
the immunoassays and prevalence of schistosome infection were
analyzed by Pearson’s correlation analysis.
We judged a P value of less than 0.05 significant. All analyses
were performed with SPSS (Statistical Products & Service
Solutions) package for windows (SPSS Inc., Chicago, USA,
version 13.0).
Results
A total of 7,996 people in seven villages voluntarily participated
in field survey. 10.27% (821/7996) of them didn’t offer stool
specimens while 6.64% (531/7996) didn’t offer serum specimens.
Of the remaining 6,644 persons, complete data were available on
both fecal and serum specimens for 6,248 and were included in the
analysis. This population, aged from 6–65 years, with a mean age
of 38.53617.76 years, was made up of 48.13% (3007/6248) men
and 51.87% (3241/6248) women.
The type of endemic areas and results of stool examination are
shown in Table 1. The prevalence of S. japonicum infection in the
seven villages, as defined by stool examination, ranged from
0.39%–8.23% with a geometric mean EPG (6S.D.) in the range
of 5.98 (67.90) to 45.04 (64.98), indicating that these endemic
areas had light infection intensity. Pearson’s correlation coeffi-
cients (r) between the prevalence of schistosome infection and
geometric mean EPG of positives was 0.89 (P,0.001), suggesting
that an excellent correlation existed between the prevalence and
intensity of schistosome infection at community level (Figure 2). All
individuals infected with schistosomes or other parasites were
given anthelminthes treatment.
The results of three immunoassays compared with those of stool
examination based on field survey were shown in Table 2 and
Figure S1. The Kappa values of immunological tests compared
with stool examination ranged from 0.08–0.16, indicating very
poor agreement between of immunoassays and parasitological
detection (P,0.001).
For the whole population, ELISA_SZ and IHA_JX had
sensitivity of 95.45% (95% CI 92.94–97.97%) and 87.50%
(95% CI 83.51–91.49%), respectively, which were significantly
higher than that of DIGFA_SH (79.55%, 95% CI 74.68–84.41%)
(P,0.05). And also the sensitivity of ELISA_SZ was notable
higher than that of IHA_JX (x2 = 10.71, P,0.05). In stratified
analysis, the sensitivity of ELISA_SZ and IHA_JX did not differ
in age strata except in the group of 20–29 years old while
DIGFA_SH presented significant difference in sensitivity among
age groups (P,0.05) (Figure 3A). All assays showed sensitivities
equal to or lower than 66.7% in the 20–29 years old group.
These may be caused by the inadequate sample size of patients
since there are only three stool positives in this age group and
both of them were with EPG no more than 40. ELISA_SZ and
IHA_JX also showed stable sensitivity among four intensity
categories (P.0.05) while the sensitivity of DIGFA_SH increased
with EPG notably (P,0.05) (Figure 3B). Chi-square analysis
showed that the sensitivity of ELISA_SZ was significantly higher
than those of IHA_JX and DIGFA_SH in subgroup with EPG in
the range of 1–40 (P,0.05) while the sensitivity of these three
assays didn’t differ in other three infection intensity categories
(P.0.05).
Table 1. Characteristics of the villages included in the study and the results of stool examination.
Province Village
Types of
endemic areas
No.
examined
Sex ratio
(male/female)
Age
(Mean±S.D.)
Prevalence of
schistosome infection
(% stool exam+)
Geometric mean
EPG for infected
(Mean ± S.D.)
Jiangxi Xinhua Marshland and
lake region
922 0.98 (457/465) 34.34620.15 4?99 15?1866?24
Jiangxi Caohui Marshland and
lake region
826 1.03 (418/408) 33.26617.31 6?78 22?0263?56
Jiangxi Jingtou Marshland and
lake region
923 0.91 (440/483) 40.90617.35 8?23 45?0464?98
Hubei Hebei Marshland and
lake region
886 0.99 (442/444) 31.96618.72 1?81 10?4867?26
Anhui Longshang Hilly and
mountainous region
1032 0.99 (512/520) 39.52615.37 0?39 5?9867?90
Anhui TieGuai Hilly and
mountainous region
843 0.70 (346/497) 48.25612.18 2?61 14?7363?18
Anui Yuye Marshland and
lake region
816 0.93 (392/424) 41.78616.48 5?39 26?5064?43
Total 6248 0.93 (3007/3241) 38.53617.76 4.23 23?7465?06
doi:10.1371/journal.pntd.0001408.t001
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Since school-aged children could be used as sentinel population
of new infection, the specificity of three immunodiagnostic tests
was analyzed in 6–9 years old subgroup compared with stool
examination (Figure 3C). ELISA_SZ, IHA_JX and DIGFA_SH
showed specificity of 89.24%(95%CI: 87.71–90.77%), 89.73%
(95%CI: 88.23–91.23%) and 90.71% (95%CI: 89.27–92.14%)
respectively. And no significant difference in specificity was
detected among these immunoassays in this subgroup of
population (P.0.05).
The screening efficacy of each immunoassay to find the patients
still shedding parasites among seropositives for the whole
population was evaluated by calculating the PPV (Table 2).
DIGFA_SH had the PPV of 13.07% (95%CI: 11.42–14.72%)
which were significantly higher than that of other two assays
(ELISA_SZ: 8.13% (95%CI: 7.17–9.09%) and IHA_JX: 9.30%
(95%CI: 8.15–10.44) with P values less than 0?001 while no
difference was detected in infectivity rate between ELISA_SZ and
IHA_JX (P.0.05).
Antibody positive rates of whole population determined by
ELISA_SZ, IHA_JX and DIGFA_SH were 49.60% ((252+2847)/
6248), 39.77% ((231+2254)/6248) and 25.72% ((210+1397)/
6248), respectively, which were significantly higher than the
prevalence rate of schistosomiasis determined by stool examina-
tion (P,0.05). But the distribution tendencies of positives
determined by each immunoassay and stool examination were
consistent in age strata for the entire population. Pearson’s
correlation coefficient (r) between the prevalence of schistosome
infection and antibody positive rates in age strata determined by
IHA_JX was detected with r value of 0.70 (P,0.001), indicating
the significant correlation between of them (Figure 4A). Antibody
positive rate determined by IHA_JX in group of 6–9 years old as a
sentinel population of schistosome infection also showed a
significant correlation with the prevalence of infection amongst
the villagers (r = 0.77, P,0.05, Figure 4B). The R-values for
ELISA_SZ and DIGFA_SH were 0.44, 0.68 respectively,
suggesting a lack of correlation.
Discussion
The control of schistosomiasis was outlined as a series of
consecutive phases changing from morbidity control to elimination
of schistosome infection [2,6,29]. As the goals in different stage of
schistosomiasis control varied, the diagnostic approach should be
adjusted [26,29,30]. In P.R. China,with the ultimate aim to
eliminate of schistosomiasis, a national programme with a
comprehensive control strategy to reduce transmission had been
implemented since 2004 [7,8,31]. During the implementation of
national programme, appropriate diagnostic tools are important to
yield accurate results to guide chemotherapy, monitor the endemic
status and evaluate the efficacy of control intervention. It is well
known that parasitological diagnosis for schistosomiasis is a poor
prognosticator with insensitivity and increased operational time
required in areas with low endemicity or intensity of infection
[11,13,14,32]. With many advantages over stool examination such
as high sensitivity, simple operation and ease of use in the field,
immunodiagnostic techniques had been developed and adopted
into national programme of schistosomiasis control in P.R. China
[6,16,18,19]. Although many immunoassays are used in the field
in P.R. China, little is known of serological tests that could be
integrated into the elimination strategy, and used in the final stage
of schistosomiasis control in P.R. China when prevalence and
intensity of schistosome infection is low [3,5].
In this study, we provided evidence that parasite density
decreases as the prevalence of schistosome infection decreases,
making it essential to switch to a more sensitive technique than
microscopy for guiding treatment, surveillance and monitoring the
Table 2. Performance characteristics of immunoassay compared with stool examination for the whole population.
Serological
tests
Stool
examination
Consistency with
stool examination
Validity for
cases detection
Screening
efficacy
positive negative Kappa value P value
Sensitivity
[% (95% CI)] P value*
PPV
[% (95% CI)] P value*
ELISA_SZ
positive 252 2847 0?08 ,0?001 95?45 (92?94–97?97) ,0?001 8?13 (7?17–9?09) ,0?001
negative 12 3137
IHA_ JX
positive 231 2254 0?10 ,0?001 87?50 (83?51–91?49) 0.01 9?30 (8?15–10?44) ,0?001
negative 33 3730
DIGFA_SH
positive 210 1397 0?16 ,0?001 79?55 (74?68–84?41) NA 13?07 (11?42–14?72) NA
negative 54 4587
CI = Confidence interval, PPV = Positive predicative value, NA=Not available.
*P values were calculated by comparing with DIGFA_SH.
doi:10.1371/journal.pntd.0001408.t002
Figure 2. Correlation between prevalence and intensity of
schistosome infection. r = Pearson’s correlation coefficient.
doi:10.1371/journal.pntd.0001408.g002
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impact of control interventions [26,30]. As test-treat is the most
cost-effective approach, immunodiagnostic assays was widely used
for identifying target for treatment [15]. We found ELISA_SZ was
more likely to be positive in individuals who had light infection
intensity compared with IHA_JX and DIGFA_SH. This advan-
tage was greater in subgroup with EPG low than 40. Considering
results obtained by serologic tests were closer to the real status and
sensitivity is given top priority for more efficient coverage with
chemotherapy in low endemic areas [17,29,33], ELISA_SZ is
appropriate as a screening tool for guiding selective chemotherapy
with praziquantel in areas where prevalence of schistosome
infection is higher than 1% in P.R. China with aim to reduce
the number of infected cases, since praziquantel is a safe
antischistosomal drug with few side-effects and toxicity [34,35].
As transmission decreases especially lower than 1%, the
treatment strategy needs to transit from selective chemotherapy
to individual treatment to avoid over-treatment and praziquantel
resistance, since studies have shown that praziquantel resistance
against S. mansoni had been induced in lab and presented in
humans in Senegal and Egypt [36–39]. Definition of individuals
for treatment in endemic areas with such low prevalence and
infection intensity needs more sensitive and specific diagnosis.
Although polymerase chain reaction (PCR) based molecular
methods had been reported for their higher sensitivity and
specificity [40–42], disadvantages including dependence on
expensive machines, complex operating procedure and long time
reaction time, limit their widespread application for primary
health-care settings. A two-step approach is the best choice until
now with serology as the primary screening tool followed by stool
examinations only for seropositive individuals [16]. The strategy
and diagnostics used in the different stages of control in Figure 1
represent the current policy in China. ELISA_SZ assay is
superior to other two assays as the screening tool for its high
sensitivity and high throughput capacity. In addition, the high
variation of geometric mean EPG of infected persons in our
studies support that stool examination is inadequate when only
one stool sample is detected in low endemic areas especially when
the prevalence of schistosome infection was lower than 1%
[11,13]. Multiple stool examination or combination of other
diagnostic methods for the positives of serological test would
improve its sensitivity for individual treatment [29]. Our study
also found that ELISA_SZ can miss some infected individuals
especially with the egg count less than 100. This may only
stimulate a relatively low antibody response which is not
detectable by ELISA. A few individuals with low egg counts
may be unlikely to spread disease further in the community. But
to target infected individuals for treatment or to eliminate
schistosomiasis, more sensitive methods need to be explored and
used such as nested PCR.
Since specific antibodies against schistosome may last at least
two years or even longer time in individuals who had past infection
and cured after effective treatment [17,25,43], consistency of
results determined by any immunological test and stool examina-
tion is very poor since the immunoassays also picked up antibodies
from old exposures and it is not appropriate to calculate specificity
of immunoassays directly by classifying seropositive–stool exam-
ination negative specimens as false-positives for the whole
population. In our studies, the specificity of three immunoassays
was calculated in subgroup of 6–9 years old since they could be
regarded as sentinel population indicating new infection [44]. The
results showed that these assays all performed high specificity
about 90%.
Figure 3. The sensitivities and specificities of three immunoassays and positives rates determined by each test. A: Sensitivities in age
strata. B: Sensitivities calculated by EPG category. C: Specificity of each immunoassay in 6–9 years old subgroups.
doi:10.1371/journal.pntd.0001408.g003
Figure 4. Correlation between antibody positive rate determined by IHA_JX and prevalence of schistosome infection. A: Relationship
of antibody positive rate and prevalence of schistosome infection of communities in age strata. B: Relationship of antibody positives in group of 6–9
years old determined by IHA_JX and infection prevalence of villagers.
doi:10.1371/journal.pntd.0001408.g004
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Although the antibody positive rate determined by any
immunological test was higher than the prevalence of schistosome
infection determined by stool examination, we noted that the
distribution tendencies of positives determined by immunoassays
and stool examination were consistent in age strata for whole
population [45]. The strong correlation of antibody positive rate
determined by IHA_JX with prevalence of schistosome infection
in age strata suggests that IHA_JX, which performed similar
sensitivity in laboratory and field settings [27], could be used as a
tool for surveillance and epidemiological study to analyze the
epidemic characteristics of schistosome infection and estimate the
distribution of high-risk infection population in communities
[27,32,45].
Immunodiagnostic techniques had been shown as effective tools
for disease surveillance through testing school-aged children in
areas where transmission of schistosome was under control
[44,46]. In our work, the notable correlation between the antibody
positive rate in children aged 6–9 years determined by IHA_JX
and the prevalence of schistosome infection of villagers support
this point and suggest that IHA_JX is an appropriate tool for
schistosomiasis surveillance after the transmission of schistosome
was under control (prevalence ,1%) through measuring antibody
response in school-aged children [47,48]. Further investigation has
recently started to explore how to identify the schistosome carriers
in community through surveillance of school-aged children in area
of low endemicity.
Furthermore, in low transmission intensity settings, screening
assay which could identify more patients who are still shedding
parasites among seropositives would be more efficient than doing
stool examination [49,50]. Here we calculated ‘‘PPV’’ to evaluate
the screening efficacy of immunoassays. Our studies showed that
DIGFA_SH was the most efficient screening assay among three
assays with the ‘‘PPV’’ of 13.07% (95%CI: 11.42–14.72%). And
with advantages over other two kinds of assays, such as quickness,
easy operation and free of apparatus, DIGFA_SH is more
appropriate for application in rural areas with limited resources
for schistosomiasis control. Considering its relative low sensitivity
especially for low infection intensity in our studies, DIGFA_SH
needs to be improved to be more sensitive.
This study had several limitations. One limitation in our study is
that the villages were not selected in a random manner and only
one village with prevalence lower than 1% was included. The
performance of immunoassays in other transmission control or
transmission interruption areas might be different. The other
limitation is that the three immunoassays are antibody-detection
based tests which cannot distinguish history of exposure from
active infection, it does not allow for estimation of the specificity of
each immunoassay since the information of schistosome exposure
history is difficult gained accurately. However, these assays could
be used for diagnosis in occasionally exposed people such as
travelers, migrants etc., and also could be used for surveillance in
low-transmission or post-transmission settings. And also further
studies focused on the cost-effectiveness of immunodiagnosis
integrated into control strategies needs to be conducted.
In conclusion, our findings indicate that, despite good
performance in laboratory setting, three immunoassays (ELI-
SA_SZ, IHA_JX and DIGFA_SH) evaluated in our field trials
perform differently in areas with different endemicity. The choice
of which test to use with the elimination strategy is dependent on
the purpose of testing, the endemic status of community and the
resources available [29,30]. ELISA_SZ is more suitable for
guiding chemotherapy of schistosome infection in regions with
moderate or low endemicity to reduce cases, and could be used as
a screening tool for individual treatment followed by sensitive and
specific definite diagnosis in areas after transmission is under
control, and IHA_JX is easily applied in the risk assessment for
epidemiological surveillance in endemic areas and certifying the
elimination of schistosomiasis with monitoring the sentinel
population while DIGFA_SH is a most efficient screening tools
for chemotherapy in low endemic areas but its sensitivity needs
further improved.
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